
Minerva Surgical, Inc.
Minerva Surgical, Inc. (UTRS) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · UTRS · as of Jun 8, 2026
Key Statistics
Explore Minerva Surgical, Inc. Data
utrs stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 4 · Buy rate: 75.0%
The UTRS analyst consensus is Buy, based on ratings from 4 Wall Street analysts over the past 3 months. The average 12-month price target is $100.00, representing +99999900.00% upside from the current price of $0.00.
Competitors & Peers
utrs competitorsStock Performance
Full HistoryAbout Minerva Surgical, Inc.
Minerva Surgical, Inc. a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the Unit…
what is minerva surgical, inc. · utrs stock overview · minerva surgical, inc. company profile · who is minerva surgical, inc. ceo · utrs OTC · minerva surgical, inc. headquarters · minerva surgical, inc. business segments
About Stock Overview & Key Data
Minerva Surgical, Inc. (UTRS) is a Healthcare company in the Medical - Healthcare Information Services industry, listed on OTC since Oct 22, 2021. As of the latest trading session, UTRS stock price is $0.00, with a market capitalization of $888. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
According to 4 Wall Street analysts, the consensus rating for Minerva Surgical, Inc. stock is Buy, with an average 12-month price target of $100.00. In fiscal year 2022, Minerva Surgical, Inc. reported revenue of $50.3M and net income of -$34.1M. For detailed data — including Minerva Surgical, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Minerva Surgical, Inc. (UTRS) stock price is $0.00. The stock is traded on OTC under the ticker symbol UTRS. The 52-week range is $0.00 – $0.00.